Back to Search Start Over

Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants.

Authors :
Velde HM
Reurink J
Held S
Li CHZ
Yzer S
Oostrik J
Weeda J
Haer-Wigman L
Yntema HG
Roosing S
Pauleikhoff L
Lange C
Whelan L
Dockery A
Zhu J
Keegan DJ
Farrar GJ
Kremer H
Lanting CP
Damme M
Pennings RJE
Source :
Human genetics [Hum Genet] 2022 Nov; Vol. 141 (11), pp. 1723-1738. Date of Electronic Publication: 2022 Feb 28.
Publication Year :
2022

Abstract

Usher syndrome (USH) is an autosomal recessively inherited disease characterized by sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP) with or without vestibular dysfunction. It is highly heterogeneous both clinically and genetically. Recently, variants in the arylsulfatase G (ARSG) gene have been reported to underlie USH type IV. This distinct type of USH is characterized by late-onset RP with predominantly pericentral and macular changes, and late onset SNHL without vestibular dysfunction. In this study, we describe the USH type IV phenotype in three unrelated subjects. We identified three novel pathogenic variants, two novel likely pathogenic variants, and one previously described pathogenic variant in ARSG. Functional experiments indicated a loss of sulfatase activity of the mutant proteins. Our findings confirm that ARSG variants cause the newly defined USH type IV and support the proposed extension of the phenotypic USH classification.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
1432-1203
Volume :
141
Issue :
11
Database :
MEDLINE
Journal :
Human genetics
Publication Type :
Academic Journal
Accession number :
35226187
Full Text :
https://doi.org/10.1007/s00439-022-02441-0